Zhanling International Ltd (ZLME) stock: key figures, P/E, revenue and dividend
Materials · United States
Price
8.50 USD
Market cap
29.25 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
72.56 %
Return on assets (ROA)
-21,030.60 %
Zhanling International Ltd financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Operating income | -39,857.00 USD | -38,486.00 USD |
| EBIT | -39,857.00 USD | -38,486.00 USD |
| Net income | -39,857.00 USD | -38,486.00 USD |
| Diluted EPS – continuing operations | -0.54 USD | -0.01 USD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Zhanling International Ltd
Zhanling International Limited does not have any significant operations. It is seeking new business opportunities. The company was formerly known as Odenza Corp. Zhanling International Limited was incorporated in 2009 and is based in Tsim Sha Tsui, Hong Kong.
More stocks
- Creatd, Inc. (CRTD)
- Future FinTech Group Inc. (FTFT)
- Xtant Medical Holdings, Inc. (XTNT)
- Aether Holdings, Inc. (ATHR)
- Inmune Bio, Inc. (INMB)
- COFFEE HOLDING CO INC (JVA)
- CEL SCI CORP (CVM)
- Forward Industries, Inc. (FWDI)
- SCYNEXIS INC (SCYX)
- Workhorse Group Inc. (WKHS)
- BriaCell Therapeutics Corp. (BCTX)
- OneMedNet Corp (ONMD)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.